Overview

Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime

Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This project is mainly to clarify the optimal treatment plan and the treatment recommendation sequence of different drugs in Chinese first-episode schizophrenia patients,to identify the optimized sequential treatment regimen for the treatment of resistance patients and provide new evidence for the revision of the guidelines for the treatment of schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Mental Health Center
Treatments:
Amisulpride
Antipsychotic Agents
Aripiprazole
Olanzapine
Paliperidone Palmitate
Risperidone
Sultopride